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Abstract   
Polycystic Ovary Syndrome (PCOS) is an endocrine disorder affecting 6-15% of women in age 
(12-45) years . It is characterized by disturbance in menstrual cycle ,androgenic features, and 
presence of multiple small cyst in ovaries in ultrasound. It is the important cause of infertility. The 
etiology of  the disease remains unclear and may be associated with insulin resistance, obesity  , 
type 2  diabetes mellitus, hyperandrogenism , environmental and familial genetic factors . PCOS 
has a role is the appearance of  hirsutism , acne  ,  hypertension and dyslipidemia with increase 
risk factor of cardiovascular disease (CVD). 
Objective : Aim of the study to investigate the pathogenicity, disease severity and early diagnosis 
roles of   follicle stimulating hormone (FSH) and  transforming growth factor-beta (TGF-β1) in 
women with polycystic ovarian syndrome.  
Conclusion : Polycystic ovarian syndrome was related to the decrease level of follicle stimulating 
hormone (FSH)  in different age groups where comprised 18.75% in PCOS patients , while 
increase marker of transforming growth factor β1(TGF- β1) where comprised 46.25%  in PCOS 
patients , these two result cause  failure of follicle growth to become mature .   
Polycystic ovarian syndrome (PCOS) 
1. Introduction         
   Polycystic ovarian syndrome (PCOS)  is the most well-known female endocrine and 
metabolic disorders  influencing (6 - 15%) of women of reproductive age (12 - 45years) and is 
believed to be one of the leading sources of  female infertility
[1]
.The  disturbance resulting 
multiple abnormal cysts in amplified  ovaries, so they  do not create the typical number of  eggs 
and do not ovulate regularly
[2]
.   
        The illness is available during childbirth  yet does not cause any symptoms till puberty.The 
essential features are obesity, anovulation (bringing about sporadic or irregular menstruation), 
acne and excessive amounts  of androgenic hormones,although the reasons of PCOS are obscure, 
yet there are solid correlation between's  insulin resistance (IR), diabetes, and obesity with 
PCOS
[3]
.Rotterdam consensus workshop demonstrated PCOS introduce if ( 2 ) out of the 
following( 3 ) criteria are found
[4]. 
:- 
1. Polycystic ovaries are present by the ultrasound. 
2. Increased  level of male hormones(androgen).  
3. Menstrual disorders.  
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The luteinizing hormone (LH) level is higher than follicle stimulating hormone (FSH) level in 
most cases of PCOS , this state is called a lifted LH to FSH proportion
[5]
.Exactly when ladies 
having PCOS implies that their ovaries are not getting the benefit hormonal signals from their 
pituitary gland, without these signals there will be no ovulation and the menstrual cycle, may be 
irregular or lost.Frequently, ladies with PCOS have high testosterone level, develop to acne, hair 
growth (hirsutsim) predominantly on the lower face, neck, chest and upper back
[6]
.In previous 
years it has become recognized that women with PCOS may be more susceptible than other 
women to a wide range of psychological problem, especially anxiety and depression, as indicated 
by a portion of the scientists in PCOS, there is still a yet far way until  the point that we set up 
authoritative causative links between the physiological and the psychological phenomena that 
happen  in PCOS
[7]
.  
              Several metabolic features are related with PCOS, include a predisposition to develop 
insulin resistance, metabolic syndrome, diabetes and obesity
, 
other metabolic issues involve 
hypertension, and non-alcoholic fatty liver disease
[8]
.The obesity is a major impact on the 
metabolic affiliations and complexities of the syndrome.  
Among different variables, obesity is clearly identified with the fruitlessness of PCOS and 
expands the hazard for metabolic disorder and the grouping of cardiovascular hazard factors in 
these ladies
[9].
  
There is a critical increment in the rate of impaired glucose tolerance (IGT) and type 2 diabetes 
mellitus (T2DM) in ladies with PCOS, this study showed that on the underlying assessment with a 
2-hours glucose tolerance test (GTT) 30-40% of  PCOS already have IGT or T2DM
[10 ]
.  
              Patients of polycystic ovarian syndrome (PCOS) are at expanded danger of increase 
levels of low density lipoprotein (LDL) , which if ignored, can prompt a heart attack or stroke. 
Alternately, women with PCOS have bring down levels of  high density lipoprotein (HDL) ,which 
is another dangerous factor for cardiovascular disease(CVD) 
[11]
, other than an assumed hereditary 
susceptibility, different features related with PCOS may influence future health of offspring, such 
as obesity and unfavorable metabolic dysfunction of the mother ,placental abnormalities, and 
increased pregnancy complications
[12]
. 
Follicle stimulating hormone (FSH) : -  
Follicle stimulating hormone is a glycoprotein dimer consisting of two subunits: α (alpha) , FSHα  
and β (beta) , FSHβ subunits. The α –subunit is consists of (92) amino acids, The β -subunit is 
consists of (118) amino acids, which allows the differential function of each hormone. FSH 
assumes a very important role  in reproductive control of ladies as a the generation and maturation 
of gonadal development amid the reproduction and differentiation of  its objective cells by join to 
its objective receptor exist on the membrane of granulosa cells
[13]
. 
On the off chance that there is a disturbance in follicular development, the FSH action will be 
unworkable
[14]
.FSH cooperation with its receptor is pivotal for the development and maturation of 
follicles, therefore any alteration in the genotype of the receptor cause defect stuck its capacity to 
connect to the FSH which prompts disorder in the signaling pathways 
[15]
.The reason for 75% of 
infertility is anovulation PCOS
[16]
.The granulosa cells of this follicles are lower sensitive to LH 
and their size is little than different follicles with typical cycle and creates unusual value of 
estradiol because of their little sizes and suppers FSH level and prohibit the normal follicular 
development
[17]
. 
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FSH regulate  granulosa cells function that makes the change of the androgen to estrogens by 
aromatase enzyme 
[18]
. 
FSH begins to rise a few days preceding the beginning of menses and is in charge of the induction 
of an accomplice of ovarian follicles and in addition a chosen of the dominant follicle. FSH 
encourage granulosa cell growth and actuates aromatase activity
[13]
.FSH level at that point begin 
to downhill owing to estrogen offspring by the growing follicular granulosa cells. In spite of this 
reduce in the FSH level, the dominant follicle keeps on developing as it ensure the most elevation 
in concentration of FSH receptors, making it increasingly impervious to the drop in FSH level 
also, the drop in FSH level causes a higher androgenic microenvironment in the non dominant 
follicles. FSH at that point decreases after ovulation of the dominant follicles
[19]
. 
Transforming growth factor- β 1 (TGF-β1):- 
Transforming growth factor-β1 (TGF-β) is a multifunctional  groups of cytokine exist in mammals 
in three isoforms (TGF-β1, TGF-β2, and TGF-β3), encoded by different genes, the TGF-1 is at 
first  synthesized as a 390 amino-acid precursor molecule called pre-pro-TGF-1 , Pre- pro-TGF-
1 then processed by many cleavage to yield mature TGF-β1[20]. TGF-β1 is useful in regulating  
multiple reproductive functions, including folliculogenesis, steroidogenesis, cumulus expansion, 
oocyte maturation, and ovulation
[21]
.They are also influence growth, differentiation, cell migration, 
formation and degradation of cell matrix components, as well as processes of chemotaxis and 
apoptosis ,TGF-β role had been exhibit in progesterone and inhibin production by granulosa 
cells
[22]
. 
TGF-β1 is normally found in the plasma and serum (TGF-β1 isoform), and bound to Extra 
Cellular Matrix (ECM) proteins throughout the body, TGF-1 also is expressed in the oocytes, 
granulosa cells and theca cells of the growing follicles, it  have seven receptors type 1 [activin-like 
kinases (ALKs) in human
[23]
.These present in both theca and granulosa cells. in normal follicles, 
of the ovary the TGF-β is responsible for the differentiation and proliferation of granulosa and 
theca cells and also inhibition of androgen production
[24]
. While in PCOS it expressed in the ovary 
and has been implicated in the pathogenesis of abnormal follicle development and 
hyperandrogenism, other factors, such as endocrine, environmental, and metabolic disorders, 
might also play an important  role in dysregulated TGF-β signaling in PCOS patients[25].TGF-β1 
levels increase  in various cardio metabolic complications, hypertension, obesity, insulin 
resistance, diabetes, and coronary artery disease
[26]
.These findings of increased TGF-β1 reveal the 
bioavailability in PCOS is consistent with an important role for TGF-β1 in the pathogenesis of the 
cardio-metabolic complications seen in Iraqi women with PCOS, TGF-β1 regulates the expression 
of genes that promote inflammation, such as interleukin 6
[27]
.Circulating and molecular markers of 
oxidative stress and inflammation are highly correlate with circulating androgens. These findings 
raise the possibility that in PCOS, either hyperandrogenemia to account for the hyperglycemia- 
induced inflammation, or conversely that glucose-stimulated inflammation promotes ovarian 
androgen production in PCOS
[28]
.TGF- β1 level dysregulated in women with PCOS, which might 
play a role in the pathophysiology of this syndrome , also implicate that TGF- β1 activation is 
associated with hypertension and endothelial dysfunction, there is dispersed guide for the 
relationship between TGF- β1, metabolic syndrome, visceral adiposity, non-alcoholic fatty  liver  
illness and T2DM 
[28]
. 
In PCOS ovaries show all the assay marks of TGF- β upregulation, including increased collagen 
deposition in ovarian theca cell, supported by angiogenesis and increased vascularity, TGF- β1 has 
been shown to be increased in the  PCOS
[29]
. genetic study exhibited Strong  indicator that TGF-
b1 dysregulation in PCOS was associated with insulin resistance in women with PCOS.A recent 
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association study in a group of  Korean women showed that single nucleotide polymorphisms in 
the TGF-1 gene were  associated with the development and characteristics of PCOS, suggesting a 
potential role for TGF-β1 in the pathogenesis of this chronic disease[30].Other recent study using 
human ovarian tissues showed that (TGF-β), supposed  TGF-β receptors, and its corresponding 
signal molecules are expressed by the various cell types (oocytes, granulosa and theca cells) of 
ovarian follicles in a different stage during  follicular growth,  these study occur by using cellular 
and molecular advanced technologies have implicated intraovarian TGF-β as crucial modulators 
of all sides of ovarian functions, from germ cell formation to follicular development, 
steroidogenesis, cell-cell connection, oocyte maturation, ovulation, and luteal function
[31]
. It is 
established that a TGF beta protein must be collapsed accurately in order to fulfill its biological 
function,on account of mutations, this factor might be misfolded, which can cause numerous 
fertility disorders, for example, primary ovarian deficiency or PCOS
[32]
.In PCOS, if defect or 
change in TGF-β signaling within the ovary reason for structural changes (eg, increased ovarian 
stroma and tunica features of  PCOS) that encourage functional changes (eg, elevated secretion of 
androgens by theca cell that surrounds the antral follicle and failure of a follicle to mature and 
develop into a dominant follicle because the increase stroma and enlarge  of the ovary), resulting 
in the PCOS reproductive phenotype of chronic hyperandrogenic anovulation
[33]
. 
2. Materials and methods 
  2.1 Subject  
        The present study comprised of 120 women (80 patients with PCOS and 40 apparently 
healthy control) recruited from Al-Furat teaching Hospital and fertility center of Al- Sadder 
medical city in Al-Najaf province .They were seen from( June/ 2018 – October/ 2018).All these 
patients and healthy control were examined for PCOS diagnosis by ultrasound ,measuring 
parameters including  follicle stimulating hormone (FSH) and transforming growth factor (TGF-
β1).The FSH measured by enzyme linked fluorescence assay (ELFA) technique by using 
minividas instrument (Biomerieux ,France)  and TGF-β1measured  by ELISA technique (Human 
,Germany). 
   2.2. Samples 
           Venous blood samples (5 mL) were collected from all patients and healthy controls by 
using disposable syringe in the sitting position , the specimens were taken during 2
nd 
_ 7
th
 days of 
the menstrual cycle (follicular phase) from those of patients and healthy control . The samples 
were collected by venous puncture and pushed slowly into a dry clean jel tubes  ,then centrifuged 
directly after drawn,  the serum from all blood samples were separated by centrifugation at (4000 
rpm) for 10 minutes. Serum markers of  FSH  was measured immediately before stored and the 
remaining of the sera were stored at  deep freeze in disposable plain plastic tubes, until the time of  
the analysis  for measure serum TGF-β1. 
2.3. A. Inclusion criteria:     
1. All patients must fulfill the international diagnostic criteria for PCOS.  
2. All subjects should be more than (15 years and less than 40) years of age.  
3. The PCOS is diagnosed for not than one year ago.  
    
  B. Exclusion criteria: 
1. Patients that do not fulfill the international diagnostic criteria for PCOS.  
2. Any diagnosed case of PCOS under current medication.  
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3. Controls with a previous history of PCOS and recovered by (medication and/or 
surgery).  
4. Patients of unexplained causes of infertility  
5. Patients with other chronic disease as autoimmune, genetic, infectious and others.   
2.4 . Statistical analysis : All the statistical analyses were done by using computer  through the 
SPSS programme (version-22). 
3.Result and discussion : 
             Table (1) : The levels of FSH and TGF-β1among studied groups. 
Variables 
Patients 
n=80 
Control 
n=40 
Statistics t test p value Sig. Mean ± SD Mean ± SD 
FSH 4.37  1.67 6.22  1.98 t=5.34,  df = 118 <0.001 
 
HS 
TGF-B 68.47 ± 23.86 39.22 ± 14.55 t = 7.109, df = 118 <0.001 
 
HS 
 
The level of FSH in sera of  patients and healthy control. 
Table (1)  and Figure (1) showed a highly significant elevation(P<0.01) in the mean concentration 
of  FSH hormones in sera of patients in comparison with the mean serum concentration of healthy 
control [FSH (4.37  1.67 mIU/mL) and (6.22  1.98 mIU/mL) respectively, with a highly 
significant difference (P<0.01), appearance when PCOS patients are compared with the healthy 
control. At an optimum cut-off level of (2.2) mIU/mL ,  FSH showed the high sensitivity and 
specificity of 92% and 100% respectively ,with the AUR 0.238 (95% Cl: 0.151- 0.325). as explain 
in table and figure (2) below . 
Table (2): ROC for studied parameters. 
Variable Cutoff AUR 95%CI Sensitivity Specificity 
FSH 2.2 0.238 0.151-0.325 92 100 
TGF-B 21.65 0.857 0.789-0.925 100 90 
 
FSH level explained a highly significant difference (P<0.01) between PCOS patients and healthy 
control, this study showed a decrease in result of  FSH hormone in PCOS patients in compared 
with healthy group, this result is an agreement  with several recent studies
 
done by Maad M. et al 
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[34]
 in Baghdad city of Al-Iraq and study done by Haldun .A
[35]
 in  Turkey. Other study in Oman 
accomplished by Gowri .V. et al 
[36]
 improved the decreases FSH levels in pcos patients below 
than healthy control these results  fits with the result in this study. While the Iraqi study in 
Baghdad done by Enas .W. et al
[37]
 explained that the level of FSH hormone  were in the normal 
range  in PCOS patients , exhibited different result with this study. 
Finally more recent study in Al-Najaf province by Zahraa. H. et al 
[38]
 appeared no significant 
difference were observed in serum FSH levels between PCOs and healthy group , the result 
disagreement with this study the reason may be due to  the  differences in the criteria followed by 
this study that  included the result of FSH must be lower in PCOS patients than control group as 
an additional factor for improved the diagnosis of PCOS. 
The result obtained from this study it is compatible with the criteria for the diagnosis of PCOS , 
where the levels of FSH hormone in PCOS patients decreased or normal level than healthy 
control. The reduction levels of FSH can be explained by the increase of the conversion of 
androstenedione in adipose tissue which additionally stimulates LH and inhibits FSH 
[39]
. 
The reduction in the concentration of follicle stimulating hormone may be due to the adrenal 
gland, which produces adrenaline, which in turn affects the concentration of FSH through the 
secretion of androgens and estrogens. We believe that these low levels of hormone may be due to 
the mechanism of  hormonal restraining of FSH by the mechanism of feedback negative, and this 
corresponds to the results of the study 
[40]
. 
The negative feedback control of FSH is critical for development of the single mature oocyte that 
characterizes normal reproductive function in women .The reduction levels of FSH lead to 
inhibition of aromatase activity thus causing accumulation of androgen, also leads to impaired 
follicular development and therefore, granulosa cell atresia and not a single follicle is permitted to 
mature enough for ovulation to occur, this is important feature of  PCOS
[41]
.  
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                      Figure (1): Boxplot of FSH levels in studied groups. 
             
Figure (2): ROC curve analysis of FSH to discriminate the studied groups. 
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The level TGF-β1 in sera of patients and healthy control. 
The serum TGF-β1 (ng/mL) in Table (1) and Figure (3) exhibited a highly significant elevation 
(P<0.01) in the mean concentration of TGF-β1in sera of patients [serum TGF-β1 (68.47  23.86) 
ng/mL] in comparison with mean serum concentration of control group [serum TGF-β1 (39.22  
14.55) ng/mL] . At an optimum cut-off value  of (21.65 ) ng/mL , TGF-β1 showed the high 
sensitivity and specificity as 100 %  and 90 % respectively ,with a AUR ( 0.857 ) (95% Cl: 0.789- 
0.925). as showed in table (2) above and figure (4) below. 
The result of this study agreed with many studies
 
 reported by Shatha. A .et al
[42]
 in Baghdad city , 
Nearmeen .M al et
 [43]
 in Egypt  and finally by Reshef .T .et al
[44]
 in America .These studies  
revealed statistically significant higher values of TGF-β1 in PCOS compared to  healthy control , 
higher values of TGF-β1 appeared in overweight and obese  PCOS compared to lean PCOS group. 
The causes of increased TGF-β1 in PCOS may associated with increased number of  follicles in 
the ovaries of women with PCOS, because it produce from granulosa , theca cell and oocyte  of 
these follicles
[45]
.Also suggested the higher AMH levels, may still lead to greater ovarian TGF-b1 
production, which could have significant local effects in the ovary. The increased TGF-b1 
bioavailability in patients with PCOS may explain several aspects of this syndrome , which TGF-
b1 is a potent growth factor involved in angiogenesis , fibroblast activation, and tissue fibrosis
[46]
. 
Thus, it may play an important role in the increased fibrosis of the ovarian stroma and theca as 
well as in the increased angiogenesis and vascularity seen in the ovaries of women with 
PCOS
[47]
.TGF-β is responsible for the differentiation and proliferation of granulosa and theca 
cells, as well as inhibition of androgen production 
[48]
. The receptors of TGF-β1 present in both 
theca and granulosa cells ,when defect occur  can effect on developing follicle in different stage of 
folliculogenesis, it can act as an inhibitor or stimulator of granulosa and theca cells proliferation. 
Also, TGF-β role had been demonstrated in progesterone and inhibin secretion by granulosa 
cells
[49]
. TGF-β1 has a regulatory effect on primordial follicle growth and is involved in 
maintaining the primordial follicle pool . It was observed that there was a decrease in the amount 
of primordial and growing follicles when ovaries were cultured with TGF-β1. Therefore, there is a 
possibility that this protein’s relatively low level enables the activation of primordial follicles [50]. 
Conditional of surgical removal of TGF-β1 receptor in mice results in the altered functionality of 
the female reproductive tract, such as defective oviduct and uterus development, and prevents 
embryo implantation, thus causes problems with fertility
[51]
. A low chronic inflammatory state, 
characterized by elevation levels of proinflammatory molecules and acute phase proteins, can be 
present in obesity and insulin resistance 
[52]
. The TGF-β1 of overweight and obese groups showed 
a higher significant positive correlation with insulin resistance, insulin. In other studies, increased 
circulating TGF-β1 levels in various cardio metabolic complications, hypertension, obesity, 
insulin resistance, diabetes, and coronary artery disease were found 
[53]
.These findings of increased 
TGF-β1 reveal the bioavailability in PCOS is consistent with an important role for TGF-β1 in the 
pathogenesis of the cardio-metabolic complications seen in Iraqi women with PCOS. Targeting 
TGF-β1 dysregulation may be particularly important in PCOS as women at increased risk of 
impaired glucose tolerance and type 2 diabetes due to underlying insulin resistance. Excessive 
TGF-β1 activity has been implicate in the pathogenesis of arterial disease in patients with altered 
glucose metabolism
[54]
.Dysregulated TGF-β1 activity may contribute to atherosclerosis by 
stimulating smooth muscle cells in the vasculature to proliferate and synthesize collagen. TGF-β1 
regulates the expression of genes that promote inflammation, such as interleukin 6 which highly 
correlate with circulating androgens 
[55]
.These findings raise the possibility that in PCOS, either 
hyperandrogenemia pre-activate mononuclear cells (MNC) to account for the hyperglycemia 
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induced inflammation, or conversely that glucose-stimulated inflammation promotes ovarian 
androgen production in PCOS. There is data to support that both mechanisms may occur
[56]
. 
 
                     Figure (3): Boxplot of TGF-β1 level in studied groups. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (4): ROC curve analysis of TGF-B to discriminate the studied groups. 
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